Publications and Presentations Database
]
(2013). Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.
Progress in neurobiology. 110, 89-101. Abstract
(2005). Genetic susceptibility testing versus family history-based risk assessment: impact on perceived risk of Alzheimer disease.
Genetics in medicine : official journal of the American College of Medical Genetics. 7(1), 48-53. Abstract
(2010). Genetic testing for Alzheimer's and long-term care insurance.
Health affairs (Project Hope). 29(1), 102-8. Abstract
(2005). Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior..
Health affairs (Project Hope). 24(2), 483-90. Abstract
(2012). Genetic testing for risk of Alzheimer’s disease: benefit or burden?.
Neurodegenerative disease management. 2(2), 141-44.
(2008). Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL Study.
Alzheimer disease and associated disorders. 22(1), 94-7. Abstract
(2015). How can psychological science inform research about genetic counseling for clinical genomic sequencing?.
Journal of genetic counseling. 24(2), 193-204. Abstract
(2010). "I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.
Genetics in medicine : official journal of the American College of Medical Genetics. 12(4), 219-27. Abstract
Download: PDF (310.84 KB)
(2017). Identification of Serratane Synthase Gene from the Fern Lycopodium clavatum..
Organic letters. 19(3), 496-499. Abstract
(2018). The impact of genetic counselors’ use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer’s disease.
Patient Education and Counseling. 101(5), 817-823. Abstract
(2017). The impact of genetic counselors’ use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer’s disease. .
Patient Education & Counseling. Abstract
(2016). The impact of personal genomics on risk perceptions and medical decision-making..
Nature biotechnology. 34(9), 912-8.
(2016). Implications of Personal Genomic Testing for Health Behaviors: The Case of Smoking..
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 18(12), 2273-2277. Abstract
(2008). Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.
Genetics in medicine : official journal of the American College of Medical Genetics. 10(3), 207-14. Abstract
(Submitted). Interpretations of the term "actionable" when discussing genetic test results: What you mean is not what I heard.
Journal of Genetic Counseling. Abstract
(2009). Living at risk: the sibling's perspective of early-onset Alzheimer's disease.
Journal of genetic counseling. 18(3), 239-51. Abstract
(2010). Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members.
Neurology. 75(5), 425-31. Abstract
(2011). Modeling decisions to undergo genetic testing for susceptibility to common health conditions: an ancillary study of the Multiplex Initiative.
Psychology & Health. 27(4), 430-44. Abstract
(2012). Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing.
Genetics in medicine : official journal of the American College of Medical Genetics. 14(2), 268-73. Abstract
(2009). A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease.
Alzheimer disease and associated disorders. 23(1), 50-6. Abstract
(2019). Next‐generation sequencing in precision oncology: Patient understanding and expectations.
Cancer Medicine. Abstract
(2013). On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing?.
Medical decision making. 33(1), 71-7. Abstract
(2018). Oncologists’ use of clinical sequencing data to inform clinical management.
JCO Precision Oncology. Abstract
